Neuroinflammation in Parkinson's disease animal models: a cell stress response or a step in neurodegeneration?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current topics in behavioral neurosciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/7854_2014_356PMID 25293443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.

  2016cited by this paper
• Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.

  2014cited by this paper
• [The role of parkin in Parkinson's disease].

  2014cited by this paper
• Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.

  2014cited by this paper
• Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats

  2014cited by this paper
• Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP/probenecid mouse model of Parkinson's disease.

  2014cited by this paper
• Differential aggregation properties of alpha-synuclein isoforms.

  2014cited by this paper
• Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)*

  2014cited by this paper
• Genetic variants and animal models in SNCA and Parkinson disease.

  2014influential reference
• Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

  2014cited by this paper
• MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

  2014cited by this paper
• Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine.

  2014cited by this paper
• Endogenous dopamine is involved in the herbicide paraquat-induced dopaminergic cell death.

  2014cited by this paper
• Neuronal vulnerability, pathogenesis, and Parkinson's disease

  2013cited by this paper
• Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.

  2013influential reference
• Neuronal vulnerability, pathogenesis, and Parkinson's disease

  2013cited by this paper
• Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System

  2013cited by this paper
• Prion-like spreading of pathological α-synuclein in brain

  2013cited by this paper
• The many faces of alpha‐synuclein mutations

  2013cited by this paper
• Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease.

  2013cited by this paper
• MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

  2013influential reference
• PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.

  2013cited by this paper
• RETRACTED: 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors.

  2013cited by this paper
• Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

  2013cited by this paper
• PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.

  2013cited by this paper
• Activation of microglia induces symptoms of Parkinson’s disease in wild-type, but not in IL-1 knockout mice

  2013cited by this paper
• Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.

  2013influential reference
• α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model.

  2013influential reference
• Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model

  2013cited by this paper
• From bench to bedside: the importance for neurodegenerative disorders of crosstalk between basic and clinical research.

  2013cited by this paper
• The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.

  2013cited by this paper
• Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

  2013influential reference
• Non-Motor and Motor Features in LRRK2 Transgenic Mice

  2013cited by this paper
• Distinct a-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

  2013cited by this paper
• Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson’s Disease

  2013cited by this paper
• Interplay of LRRK2 with chaperone-mediated autophagy

  2013cited by this paper
• Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1−/− mice

  2013cited by this paper
• LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors

  2012cited by this paper
• Interferon-γ plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways.

  2012cited by this paper
• Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice

  2012influential reference
• The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling

  2012cited by this paper
• Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia

  2012cited by this paper
• Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease

  2012cited by this paper
• Lewy pathology and neurodegeneration in premotor Parkinson's disease

  2012cited by this paper
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.

  2012cited by this paper
• Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease

  2012influential reference
• Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

  2012cited by this paper
• Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates.

  2012cited by this paper
• Cellular models to investigate biochemical pathways in Parkinson’s disease

  2012cited by this paper
• Conditional Expression of Parkinson's Disease-Related Mutant α-Synuclein in the Midbrain Dopaminergic Neurons Causes Progressive Neurodegeneration and Degradation of Transcription Factor Nuclear Receptor Related 1

  2012cited by this paper
• Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

  2012cited by this paper
• Viral-toxin interactions and Parkinson’s disease: poly(I:C) priming enhanced the neurodegenerative effects of paraquat

  2012cited by this paper
• LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

  2012cited by this paper
• LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors

  2012cited by this paper
• Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies

  2012cited by this paper
• Neuroprotection by Silencing iNOS Expression in a 6-OHDA Model of Parkinson’s Disease

  2012cited by this paper
• Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.

  2012cited by this paper
• PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation

  2012cited by this paper
• Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation

  2012cited by this paper
• Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease

  2012influential reference
• Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.

  2012cited by this paper
• Neurotoxin-based models of Parkinson's disease.

  2012cited by this paper
• The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities

  2012cited by this paper
• Inflammation in Parkinson's disease.

  2012cited by this paper
• Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease

  2012influential reference
• PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1

  2012cited by this paper
• Role of Secondary Mediators in Caffeine-Mediated Neuroprotection in Maneb- and Paraquat-Induced Parkinson’s Disease Phenotype in the Mouse

  2012cited by this paper
• Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice

  2012cited by this paper
• CNS infections, sepsis and risk of Parkinson's disease.

  2012cited by this paper
• Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression.

  2012cited by this paper
• A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells.

  2012cited by this paper
• IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease

  2011cited by this paper
• Neuroinflammation and α-Synuclein Dysfunction Potentiate Each Other, Driving Chronic Progression of Neurodegeneration in a Mouse Model of Parkinson’s Disease

  2011cited by this paper
• Natural toxins implicated in the development of Parkinson’s disease

  2011cited by this paper
• Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment

  2011cited by this paper
• Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B

  2011influential reference
• Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice.

  2011influential reference
• CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease

  2011cited by this paper
• Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

  2011cited by this paper
• Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease.

  2011cited by this paper
• Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK.

  2011cited by this paper
• The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation

  2011cited by this paper
• Lipopolysaccharide Animal Models for Parkinson's Disease

  2011cited by this paper
• Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake

  2011cited by this paper
• Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration.

  2011cited by this paper
• A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2

  2011cited by this paper
• The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease

  2011cited by this paper
• Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.

  2011cited by this paper
• PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

  2011cited by this paper
• Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice

  2011cited by this paper
• CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease

  2011cited by this paper
• Triptolide Down‐regulates COX‐2 Expression and PGE2 Release by Suppressing the Activity of NF‐κB and MAP kinases in Lipopolysaccharide‐treated PC12 Cells

  2011influential reference
• Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons

  2011cited by this paper
• Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle

  2011cited by this paper
• The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

  2011cited by this paper
• Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions

  2011cited by this paper
• Ethanolic Extract of Fructus Alpinia oxyphylla Protects Against 6-Hydroxydopamine-Induced Damage of PC12 Cells In Vitro and Dopaminergic Neurons in Zebrafish

  2011cited by this paper
• E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment*

  2011influential reference
• Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease

  2010cited by this paper
• Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model.

  2010cited by this paper

• Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson’s disease

  2025cites this paper
• Physical activity affects DNA methylation-derived inflammation markers in a community-based Parkinson's disease study

  2025cites this paper
• The role of the hippocampus and SLC39A8 in chronic musculoskeletal pain-induced dementia: a Mendelian randomization study

  2025cites this paper
• Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease.

  2024cites this paper
• The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson's disease.

  2024cites this paper
• Long-Term Impact of Diffuse Traumatic Brain Injury on Neuroinflammation and Catecholaminergic Signaling: Potential Relevance for Parkinson’s Disease Risk

  2024cites this paper
• Chemiexcitation: Mammalian Photochemistry in the Dark†

  2023cites this paper
• Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop

  2022cites this paper
• WDR43 is a potential diagnostic biomarker and therapeutic target for osteoarthritis complicated with Parkinson’s disease

  2022cites this paper
• Immune-related biomarkers for Parkinson's disease.

  2022cites this paper
• Celastrol Downmodulates Alpha-Synuclein-Specific T Cell Responses by Mediating Antigen Trafficking in Dendritic Cells

  2022cites this paper
• Lactobacillus plantarum DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson's Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder.

  2022cites this paper
• Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease.

  2022cites this paper
• Association of Osteoarthritis With Increased Risk of Parkinson's Disease: A Population‐Based, Longitudinal Follow‐Up Study

  2021cites this paper
• Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

  2021cites this paper
• Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation

  2020cites this paper
• Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson’s Disease: A Comparative Study

  2020cites this paper
• α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

  2020cites this paper
• Higher risk of Parkinson disease in patients with primary Sjögren’s syndrome

  2020cites this paper
• Selective neuronal vulnerability in Parkinson's disease.

  2020cites this paper
• Neuroprotective effects of melatonin against neurotoxicity induced by intranasal sodium dimethyldithiocarbamate administration in mice.

  2020cites this paper
• Effects of progesterone at the enteric level in a mouse model of Parkinson's disease

  2019cites this paper
• Deficiency of α1,6-fucosyltransferase promotes neuroinflammation by increasing the sensitivity of glial cells to inflammatory mediators.

  2019cites this paper
• 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.

  2019cites this paper
• Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity

  2019cites this paper
• Changes in the Immune System in Parkinson’s Disease

  2019cites this paper
• Widespread Tau-Specific CD4 T Cell Reactivity in the General Population

  2019cites this paper
• RTA 408 Inhibits Interleukin-1β-Induced MMP-9 Expression via Suppressing Protein Kinase-Dependent NF-κB and AP-1 Activation in Rat Brain Astrocytes

  2019cites this paper
• Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders

  2019cites this paper
• Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease

  2019cites this paper
• Co-signaling Molecules in Neurological Diseases.

  2019cites this paper
• Parkin Protein: The Missing Link Between Cardiovascular and Parkinson’s Disease

  2019cites this paper
• EFFECTS OF THE G2019S LRRK2 MUTATION ON MOTOR LEARNING IN MICE

  2018cites this paper
• Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

  2018cites this paper
• New insights on Parkinson's disease from differentiation of SH-SY5Y into dopaminergic neurons: An involvement of aquaporin4 and 9

  2018cites this paper
• Chemiexcitation and Its Implications for Disease.

  2018cites this paper
• Adverse Outcome Pathway on Inhibition of the mitochondrial complex I of nigro-striatal neurons leading to parkinsonian motor deficits

  2018cites this paper
• Insights into the Cyclooxygenase Pathway in a Progressive Rat Model of Parkinson’s Disease Induced by Prostaglandin J2: Protection with Ibuprofen

  2018cites this paper
• Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration

  2018cites this paper
• Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

  2018cites this paper
• Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets

  2018cites this paper
• Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson’s Disease in Rats

  2018cites this paper
• Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease

  2018cites this paper
• Heat shock protein 70 suppresses neuroinflammation induced by &agr;‐synuclein in astrocytes

  2018cites this paper
• T cells of Parkinson’s disease patients recognize α–synuclein peptides

  2017cites this paper
• Interleukin‐10 inhibits neuroinflammation‐mediated apoptosis of ventral mesencephalic neurons via JAK‐STAT3 pathway

  2017cites this paper
• Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease.

  2017cites this paper
• Are rodent models of Parkinson's disease behaving as they should?

  2017cites this paper
• Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism

  2017cites this paper
• Selective neuronal vulnerability in Parkinson disease

  2017cites this paper
• GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease

  2017cites this paper
• Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model

  2016cites this paper
• Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson’s disease

  2016cites this paper
• Investigating Monoamine Regulation: The Transport Of The Dopamine Transporter To Striatal Terminals And The Effects Of Tyrosine Hydroxylase Overexpression On Dopaminergic and Noradrenergic-Related Phenotypes

  2016cites this paper
• Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats

  2016cites this paper
• Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.

  2016cites this paper
• Inflammation: Role in Parkinson's Disease and Target for Therapy

  2016influential citation
• Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson's disease model in rats

  2015cites this paper
• Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?

  2015cites this paper
• Evaluation of Pharmacological Potential of Abietic Acid Against Rotenone Induced Parkinsonism in Caenorhabditis Elegans

  year unknowncites this paper